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Abstract
Aim: ATP-binding cassette transporter A1 (ABCA1) is an important mediator of macrophage cholesterol efflux. It mediates
the efflux of cellular cholesterol to lipid-poor apolipoprotein A-I. LDL receptor (LDLr) knockout (KO) mice deficient for
leukocyte ABCA1 (ABCA1 KORLDLr KO) show increased atherosclerosis and splenic lipid accumulation despite largely
attenuated serum cholesterol levels. In the present study, we aimed to explore the importance of the spleen for the
atheroprotective effects of leukocyte ABCA1.
Methods: LDLr KO mice were transplanted with bone marrow from ABCA1 KO mice or wild-type (WT) controls. After 8
weeks recovery, mice were either splenectomized (SP-x) or underwent a sham operation, and were subsequently challenged
with a Western-type diet (WTD).
Results: In agreement with previous studies, the atherosclerotic lesion area in ABCA1 KORLDLr KO sham animals
(6556826103 mm2) was 1.4-fold (p = 0.03) larger compared to sham WTRLDLr KO mice (4596336103 mm2) after 8 weeks
WTD feeding, despite 1.7-fold (p,0.001) lower serum cholesterol levels. Interestingly, deletion of ABCA1 in leukocytes led to
1.6-fold higher neutrophil content in the spleen in absence of differences in circulating neutrophils. Levels of KC, an
important chemoattractant for neutrophils, in serum, however, were increased 2.9-fold (p = 0.07) in ABCA1 KORLDLr KO
mice. SP-x induced blood neutrophilia as compared to WTRLDLr KO mice (1.9-fold; p,0.05), but did not evoke differences
in serum cholesterol and anti-oxLDL antibody levels. Atherosclerotic lesion development, however, was 1.3-fold induced
both in the presence and absence of leukocyte ABCA1 (WT: 61461066103 mm2, ABCA1 KO: 7866446103 mm2). Two-way
ANOVA revealed independent effects on atherosclerosis for both leukocyte ABCA1 deficiency and SP-x (p,0.05).
Conclusions: The observed splenic alterations induced by leukocyte ABCA1 deficiency do not play a significant role in the
anti-atherogenic effects of leukocyte ABCA1 on lesion development.
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Introduction
Reverse cholesterol transport (RCT) is an important mechanism
by which HDL and its major apolipoprotein A-I (apoA-I) protect
against atherosclerosis. [1] In this process, the cellular cholesterol
efflux machinery is essential to maintain cellular lipid homeostasis
in macrophages and to prevent pathological foam cell formation, a
hallmark of atherosclerosis. A key regulator of macrophage
cholesterol efflux is ATP-binding cassette (ABC) transporter
ABCA1, which facilitates cholesterol efflux to lipid-poor apolipo-
proteins like apoA-I, [2] thereby initiating the generation of HDL.
[3,4] Deficiency of leukocyte ABCA1 on the LDLr KO
background (ABCA1 KORLDLr KO) led to increased athero-
sclerosis, despite largely attenuated cholesterol levels. [5] Interest-
ingly, these mice also showed elevated leukocyte counts in the
circulation, [6] and accumulation of macrophages in the
peritoneal cavity, liver, and spleen. [5] This indicates that
leukocyte ABCA1, in addition to its role in cholesterol efflux,
exerts regulatory functions in the recruitment of inflammatory cells
to the periphery.
The spleen is the largest lymphoid organ in the body with
important immunological functions. It produces antibodies,
facilitates phagocytosis and is capable of eliminating foreign
antigens. [7,8] However, it also serves as a blood filter by removing
old and abnormal red blood cells, [9] and functions as an
important monocyte reservoir. [10] Since atherosclerosis is
believed to result from a combination of dyslipidemia and vascular
inflammation, [11] the role of the spleen with respect to
atherosclerosis and serum lipid levels has been thoroughly
investigated.[12–16] It has been previously reported that total
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cholesterol (TC) levels increase after splenectomy. [12,13]
However, Western-type diet fed, splenectomized apoE KO mice
display increased atherosclerosis as compared to sham-operated
controls, without changes in TC levels. [15,17].
To investigate the possible interplay between the spleen and
leukocyte ABCA1 with respect to the development of atheroscle-
rosis, we transplanted bone marrow from ABCA1 deficient mice
into LDLr deficient recipient mice, which were subsequently either
splenectomized or underwent a sham operation. Our results
evidently show that leukocyte ABCA1 deficiency resulted in
decreased TC levels, increased inflammation, and lipid and
neutrophil accumulation in the spleen. However, the observed
splenic alterations induced by leukocyte ABCA1 deficiency did not
alter anti-oxLDL antibody levels, nor played a significant role in
atherosclerotic lesion development as evidenced by splenectomy.
Methods
Animals, Bone Marrow Transplantation, and Splenectomy
Animal experiments were approved by the Ethics Committee
for Animal Experiments of Leiden University (permit number
09171) and performed at the Gorlaeus Laboratories of the
Leiden/Amsterdam Center for Drug Research in accordance
with the National Laws and the Directive 2010/63/EU of the
European Parliament.
C57BL/6J mice and ABCA1 KO [18] mice (more than 7 times
backcrossed onto a C57BL/6J background) were used as donors
for the bone marrow transplantation. These donor mice were
anaesthetized by subcutaneous injection with a mix of 70 mg/kg
body weight xylazine, 1.8 mg/kg bodyweight atropine and
350 mg/kg body weight ketamine. Animals were subsequently
sacrificed by cervical dislocation. Homozygous C57BL/6J LDL
receptor knockout (LDLr KO) mice were obtained from The
Jackson Laboratory as mating pairs and bred at the Gorlaeus
Laboratories, Leiden, The Netherlands. Bone marrow transplan-
tations into LDLr KO mice were performed as described. [19]
Briefly, irradiated recipients ($11 per group) received 56106 bone
marrow cells by intravenous injection into the tail vein. After 8
weeks, mice were either splenectomized (SP-x) or underwent a
sham operation. Mice were anesthetized with isoflurane inhala-
tion. After anesthesia, mice were surgically prepared by first
shaving the incision site, followed by preparing the incision site
with alcohol. A small incision was made in the left subcostal
abdominal wall, through which the spleen was exteriorized.
Splenectomy was performed by placing ligatures around the
splenic vasculature and subsequently removing the spleen. The
incision was closed in two layers using surgical sutures. Mice were
monitored for recovery from anesthesia and kept at 37uC until
wakeup. Control mice underwent a sham operation and were
maintained in the same conditions.
After a recovery period of 2 weeks, the animals were challenged
with a Western-type diet (WTD; 0.25% cholesterol and 15%
cocoa butter; Special Diet Services, Witham, Essex, UK) for 8
weeks to induce atherosclerotic lesion development. At 18 weeks
after transplantation, mice were anaesthetized by subcutaneous
injection with a mix of 70 mg/kg body weight xylazine, 1.8 mg/kg
bodyweight atropine and 350 mg/kg body weight ketamine.
Animals were subsequently sacrificed by cervical dislocation.
Histological Analysis of the Aortic Root and Spleen
To analyze the development of atherosclerosis at the aortic root,
transplanted LDLr KO mice were euthanized 18 weeks after bone
marrow transplantation. The arterial tree was perfused in situ with
PBS (100 mm Hg) for 10 min via a cannula in the left ventricular
apex. The heart plus aortic root and the aortic arch were excised
and stored in 3.7% neutral-buffered formalin (Formal-fixx;
Shandon Scientific Ltd, Runcorn, UK). Serial sections (10 mm)
of the aortic root were cut using a Leica CM3050S cryostat. The
atherosclerotic lesion areas in oil red-O stained cryostat sections of
the aortic root were quantified using the Leica image analysis
system, consisting of a Leica DMRE microscope coupled to a
video camera and Leica Qwin Imaging software (Leica Ltd,
Cambridge, UK). Mean lesion area (in mm2) was calculated from
10 consecutive oil red-O stained sections of the aortic root, starting
at the appearance of the tricuspid valves. Collagen content of the
lesions was determined after Masson Trichrome staining (Sigma
diagnostics, St Louis, MO). Furthermore, acellular areas were
quantified as the area lacking nuclei in Masson Trichrome/
hematoxylin-stained sections. Sections were stained immunohis-
tochemically for the presence of neutrophils and macrophages
using a rat Ly6G antibody (monoclonal rat IgG2b, dilution 1:100;
eBioscience, San Diego, CA), and a MoMa-2 antibody (dilution
1:50; Serotec Ltd, Oxford, UK), respectively. A goat anti-rat
antibody coupled to horse radish peroxidase (HRP) (1:100) (Dako,
Glostrup, Denmark) was used as a secondary antibody and Nova
red substrate (Vector Laboratories, Burlingame, California) was
used for visualization of HRP. In addition, 7 mm cryosections of
formalin-fixed spleen from the transplanted sham-operated LDLr
KO mice were prepared and stained for neutrophils using a rat
Ly6G antibody (monoclonal rat IgG2b, dilution 1:100;
eBioscience, San Diego, CA), and counterstained with hematox-
ylin.
Lipid Analysis
At 8 weeks after bone marrow transplantation, 100 mL of blood
was drawn from each individual mouse by tail bleeding after an
overnight fasting period. Upon sacrifice, 18 weeks after bone
marrow transplantation, blood was collected by retro-orbital
venous plexus puncture after an overnight fasting period. Total
cholesterol and triglyceride analyses were performed as described.
[19].
Serum Antibody Detection
Murine monocyte chemoattractant protein-1 (MCP-1; BD
Biosciences, Erembodegem, Belgium) and keratinocyte chemoat-
tractant (KC; Biosource) serum levels were assayed using an
ELISA kit according to the manufacturer’s protocol. IgM and
IgG2a levels against oxLDL were detected in serum using
antibodies recognizing mouse IgM/IgG2a and HRP-labeled goat
anti-rat Ig (BD Pharmingen). OxLDL (5 mg/mL) was dissolved in
NaHCO3/Na2CO3 buffer (pH 9.6) and was coated overnight
onto a flat-bottom 96-well high binding plate (Corning, New York,
USA). Absorbance was detected at 450 nm.
Flow Cytometry
Upon sacrifice, blood was collected from the transplanted
animals. Erythrocytes were lysed using erythrocyte lysis buffer
(0.15M NH4Cl, 10 mM NaHCO3, 0.1 mM EDTA, pH 7.3). For
the detection of CD11b+GR-1+ neutrophils, the blood cells were
stained for the surface markers CD11b and GR-1 (0.25 mg Ab/
200,000 cells). Antibodies were purchased from eBioscience,
Vienna, Austria). Fluorescent activated cell sorting (FACS)
analyses were performed on a FACS Canto II (BD Biosciences,
Mountain View, CA). Data were analyzed using FACSDiva
software (BD Biosciences).
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Statistical Analysis
Statistically significant differences among the means of the
different populations were tested using analysis of variance
(ANOVA) and when specifically indicated the unpaired Student’s
t-test (GraphPad InStat and Prism software). The Student-
Newman-Keuls multiple comparison test was performed after
ANOVA. Two-way ANOVA was used to check possible
interactions. The probability level (alpha) for statistical significance
was set at 0.05. Results are expressed as an average 6 SEM.
Results
Increased Splenic and Systemic Inflammation in ABCA1
KORLDLr KO Mice
Deficiency of leukocyte ABCA1 has been shown to induce the
number of leukocytes in the circulation. In addition, the spleens of
these mice exhibited increased macrophage accumulation. [6] In
the current study, we observed induced concentrations of the
proinflammatory cytokines MCP-1 (2.2-fold; p,0.05), and KC
(murine IL-8; 2.9-fold; p = 0.07) in serum of ABCA1 KORLDLr
KO mice (Fig. 1). Interestingly, IL-8 is one of the most potent
chemoattractants for neutrophils. [20,21] In agreement, spleen
sections stained for Ly6G revealed increased neutrophil presence
in spleens from ABCA1 KORLDLr KO mice. This observation
was confirmed by FACS analysis on the spleen, which showed that
the splenic neutrophil content was increased 1.6-fold (p,0.01) in
ABCA1 KORLDLr KO mice compared to WTRLDLr KO
mice (Fig. 1). In order to establish the importance of the spleen for
the atheroprotective effects of leukocyte ABCA1, we subjected
WTRLDLr KO and ABCA1 KORLDLr KO mice to splenec-
tomy.
No Effects of Splenectomy on Serum Total Cholesterol,
Triglyceride and Anti-oxLDL Levels
Cholesterol levels were measured at 8 weeks (chow diet) and at
18 weeks (WTD, containing 0.25% cholesterol and 15% cocoa
butter) after bone marrow transplantation (BMT; Table 1). On
chow diet, total cholesterol (TC) levels were not different between
the groups. As expected, after feeding WTD, serum TC levels of
WTRLDLr KO mice increased <4.5-fold. However, in agree-
ment with previous studies, [6,22,23] deletion of ABCA1 in bone
marrow cells resulted in an attenuated increase in plasma TC
levels upon feeding the atherogenic diet (<2.9-fold as compared to
both SP-x (p,0.05) and sham operated controls (p,0.01)). No
differences were observed between splenectomized animals and
sham operated controls. In addition, during WTD feeding
triglyceride (TG) levels were unaffected in all experimental groups
(Table 1). Furthermore, splenectomized mice did not show altered
antibody titers of anti-oxLDL IgM and IgG2a on WTD (Table 1).
ABCA1 KORLDLr KO mice exhibited slightly decreased anti-
oxLDL antibody titers as compared to WTRLDLr KO mice.
However, these values did not reach statistical significance. These
data indicate that splenectomy did not induce significant changes
in TC, TG, and anti-oxLDL antibody response.
Increased Neutrophil Levels in Splenectomized ABCA1
KORLDLr KO Mice
Upon sacrifice after 8 weeks of WTD feeding, FACS analysis
was performed to measure MCP-1 and KC levels, as well as
neutrophil content in the blood. Splenectomy did not result in
differences in MCP-1 and KC levels as compared to controls.
Although ABCA1 KORLDLr KO mice exhibited increased
splenic neutrophil content, no differences in neutrophil levels were
observed in blood between WTRLDLr KO and ABCA1
KORLDLr KO sham operated animals. Upon splenectomy,
however, ABCA1 KORLDLr KO mice displayed a 1.9-fold
increase in neutrophil levels in blood compared to splenectomized
WTRLDLr KO mice (p,0.05; Fig. 2).
Increased Atherosclerosis in Splenectomized
Transplanted LDLr KO Mice
Atherosclerotic lesion size and composition in the aortic root of
the transplanted animals were analyzed after feeding the mice a
WTD for 8 weeks. As expected, quantification of the lesion sizes in
oil red-O stained sections of the aortic root of sham-operated
animals showed that ABCA1 KORLDLr KO mice exhibited a
1.4-fold increase (t-test; p = 0.03) in the mean atherosclerotic lesion
size compared to lesions from WTRLDLr KO mice
(6556826103 mm2 and 4596336103 mm2, respectively; Fig. 3).
Splenectomy induced a 1.2- and 1.3-fold increase in atheroscle-
rotic lesion formation in ABCA1 KORLDLr KO mice
(7866446103 mm2) and WTRLDLr KO mice
(61461066103 mm2), respectively (Fig. 3). In ABCA1 KORLDLr
KO mice the percentage of macrophages per lesion area was
attenuated (p,0.05; Fig. 4), indicative of more advanced lesions.
The acellular regions as well as the neutrophil and collagen
content per lesion area were not changed significantly (Fig. 4),
although the absolute size of the acellular regions (WTRLDLr
KO SHAM: 2966326103 mm2, ABCA1 KORLDLr KO
SHAM: 4816806103 mm2, WTRLDLr KO SP-x:
3996896103 mm2, ABCA1 KORLDLr KO SP-x:
5976116103 mm2; p= 0.01), neutrophil and collagen positive
area (data not shown) was increased, in agreement with the overall
increased lesion size. Two-way ANOVA was used to verify the
independent effects of leukocyte ABCA1 deficiency and splenec-
tomy on atherosclerotic lesion development. This test showed
significant, independent contributions of both leukocyte ABCA1
deficiency (p = 0.012) and splenectomy (p = 0.048) to the observed
increases in atherosclerotic lesion development, demonstrating the
particular importance of both leukocyte ABCA1 and the spleen
with respect to atherosclerosis.
Discussion
The importance of ABCA1 in cellular cholesterol transport
became clear when mutations in the ABCA1 gene were discovered
to cause Tangier disease, an HDL deficiency disorder. [24]
Additional research revealed a critical role for ABCA1 in
leukocytes, as it was shown to facilitate macrophage cholesterol
efflux. [25] As a consequence, deficiency of ABCA1 in leukocytes
resulted in increased atherosclerotic lesion development. [6,26]
However, more recent findings also suggested an anti-inflamma-
tory role for leukocyte ABCA1 in atherosclerosis.[27–29] In
agreement, the current study showed highly induced concentra-
tions of MCP-1 and KC (murine IL-8) in the serum of ABCA1
KORLDLr KO mice fed a WTD. MCP-1 is an important
chemoattractant for mononuclear cells. Mice deficient for MCP-1
or its receptor chemokine receptor 2 (CCR-2) develop fewer and
smaller atherosclerotic lesions than control mice, as a consequence
of the reduced ability to recruit monocytes to sites in the arterial
wall prone to atherosclerotic lesion development.[30–32] KC
(murine IL-8) triggers monocyte arrest on early atherosclerotic
endothelium, [33] and plays a central role in macrophage
accumulation in established fatty streak lesions. [34] The increased
KC and MCP-1 levels in mice lacking ABCA1 seem to be an
apparent contradiction with the observed decrease in the amount
of macrophages per lesion area, but this is likely the consequence
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Figure 1. Highly induced concentrations of the pro-inflammatory cytokines MCP-1 and KC (murine IL-8) in serum and increased
splenic neutrophil content in ABCA1 KORLDLr KO mice. Serum was obtained from WTD fed WTRLDLr KO and ABCA1 KORLDLr KO mice.
Serum MCP-1 and KC levels were determined by ELISA (A, B). n$4 mice 6 SEM per group. After red blood cell lysis, splenic neutrophil content
(CD11b+GR-1+ cells) was analyzed by FACS (C, left panel). Values represent the percentage of total spleen cells. n$6 mice 6 SEM per group.
Representative spleen sections were stained with an anti-Ly6G antibody (original magnification 100x; C, right panels). *p,0.05, **p,0.01.
doi:10.1371/journal.pone.0048080.g001
Table 1. Serum TC, TG and anti (a)-oxLDL antibody levels were measured at 10 and/or 18 weeks after BMT.
Donor
Bone
Marrow
Time
(wks) Diet
Body
Weight
(g)
Total Cholesterol
(mg/dL)
Trigly-
cerides
(mg/dL)
a-oxLDL
IgM
(OD)
a-oxLDL
IgG2a
(OD)
WTR
LDLr KO Sham
10 Chow 2960.6 354626 n.d. n.d. n.d.
18 WTD 2760.5 1137671 6869 1.1060.38 0.2560.01
ABCA1 KO
R LDLr KO sham
10 Chow 2860.5 32365 n.d. n.d. n.d.
18 WTD 2961.3 676630** 62611 0.8560.47 0.1760.02
WT R
LDLr KO SP-x
10 Chow 2860.7 299617 n.d. n.d. n.d.
18 WTD 2760.8 11446177 7466 1.2660.15 0.2760.05
ABCA1 KO R
LDLr KO SP-x
10 Chow 2861.0 247619** n.d. n.d. n.d.
18 WTD 2861.4 713654* 100626 0.8860.07 0.2160.08
Data represent mean 6 SEM of $10 mice. *p,0.05, **p,0.01, compared to respective WT. n.d. indicates not determined.
doi:10.1371/journal.pone.0048080.t001
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of the fact that mice lacking leukocyte ABCA1 develop more
advanced lesions. Interestingly, IL-8 is also one of the most potent
chemoattractants for neutrophils. [20,21] Neutrophils are short-
lived phagocytic cells that serve as essential early cellular effectors
of innate immunity and constitute the ‘‘first line of defense’’.
Accordingly, ABCA1 KORLDLr KO mice exhibited increased
neutrophil presence in the spleen. Upon splenectomy, ABCA1
KORLDLr KO mice developed blood neutrophilia as compared
to WTRLDLr KO mice. Surprisingly, leukocyte ABCA1
deficiency or splenectomy alone did not alter blood neutrophil
concentrations. In response to inflammatory processes, neutrophils
are rapidly mobilized from the bone marrow, creating a blood
neutrophilia. [35] Following their accumulation at sites of
inflammation, neutrophils become apoptotic and are efficiently
cleared, primarily by the liver and the spleen, [36] in order to
prevent excessive tissue damage. The observed blood neutrophilia
in splenectomized ABCA1 KORLDLr KO mice might be the
combined result of a chronic advanced inflammatory status
because of the lack of macrophage ABCA1, and absence of
splenic neutrophil clearance.
Of note, despite the increased presence of neutrophils in the
circulation of splenectomized ABCA1 KORLDLr KO mice, no
differences were observed in the amount of neutrophils per lesion
area present in atherosclerotic plaques of these mice. The half-life
of the neutrophils in the plaque might be too short to allow
detection of increased neutrophil presence. [37] On the other
hand, differential results on the relation between lesional and
circulating neutrophils have recently been published, [38,39]
indicating that higher levels of circulating neutrophils do not
always result in increased numbers of lesional neutrophils.
The spleen is also associated with systemic immune responses in
which it is the principal organ responding to antigens such as
oxLDL. [17] OxLDL deposits in the arterial wall are believed to
be involved in the initiation of atherosclerosis by damaging the
vascular endothelium and engulfment by macrophages. [40]
Accordingly, anti-oxLDL antibody serum titers have been
suggested to play an anti-atherogenic role. [17] Anti-oxLDL
antibody production, however, might also be increased as a result
of enhanced inflammation. No differences in anti-oxLDL antibody
serum titers were observed upon splenectomy. Deficiency of
leukocyte ABCA1 resulted in a moderate decrease in anti-oxLDL
Figure 2. Increased levels of circulating neutrophils in sple-
nectomized ABCA1 KORLDLr KO mice. At 18 weeks after BMT,
blood was drawn from WTRLDLr KO and ABCA1 KORLDLr KO mice.
After red blood cell lysis, neutrophil content (CD11b+GR-1+ cells) was
analyzed by FACS. Values are the percentage of total white blood cell
counts. n$3 mice 6 SEM per group. *p,0.05 compared to
splenectomized controls.
doi:10.1371/journal.pone.0048080.g002
Figure 3. Independent effects on atherosclerosis for both leukocyte ABCA1 deficiency and splenectomy. Quantification of
atherosclerotic lesion sizes of WTRLDLr KO and ABCA1 KORLDLr KO mice after 8 weeks of WTD feeding (left panel). Representative oil red-O stained
cross-sections (original magnification 50x; right panels). Values represent the means of the average lesion size in 10 consecutive aortic root sections
per mouse. n$8 mice 6 SEM per group. *p,0.05 compared to respective WT controls; #p,0.05 compared to sham operated controls.
doi:10.1371/journal.pone.0048080.g003
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antibody serum titers. This might be the direct result of the
attenuated serum TC levels in ABCA1 KORLDLr KO mice,
since serum TC levels have been positively correlated to serum
titers of anti-oxLDL antibodies. [41].
The importance of the spleen in lipid metabolism has been
investigated previously.[12–14] However, differential results were
obtained regarding serum TC and TG concentrations after
splenectomy. Splenectomized apoE KO mice displayed increased
atherosclerotic lesion development as compared to their sham
operated littermates, in absence of changes in serum TC levels.
[15] As expected, the current study revealed attenuated TC levels
in ABCA1 KORLDLr KO mice. However, no differences in TC
levels were observed as a result of splenectomy.
Despite the fact that splenectomy did not lead to differences in
either serum TC and TG levels, or anti-oxLDL antibody titers,
splenectomized mice did show enhanced atherosclerotic lesion
development. As expected, ABCA1 KORLDLr KO mice also
revealed increased atherosclerotic lesion formation. Moreover,
splenectomized ABCA1 KORLDLr KO mice exhibited an
additional increment in lesion development. These results suggest
that the observed splenic alterations induced by leukocyte ABCA1
deficiency do not play a significant role in the anti-atherogenic
effects of leukocyte ABCA1. Leukocyte ABCA1 deficiency, as well
as splenectomy independently induce atherosclerotic lesion devel-
opment, demonstrating the particular importance of both leuko-
cyte ABCA1 and the spleen with respect to atherosclerosis.
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